Targeting neoantigens to augment antitumour immunity.

Abstract excerpt

The past decade of cancer research has been marked by a growing appreciation of the role of immunity in cancer. Mutations in the tumour genome can cause tumours to express mutant proteins that are tumour specific and not expressed on normal cells (neoantigens). These neoantigens are an attractive immune target because their selective expression on tumours may minimize immune tolerance as well as the risk of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adoptive Transfer
• Share to Antigens, Neoplasm
• Share to Immunotherapy